The SRC family kinase inhibitor NXP900 demonstrates potent antitumor activity in squamous cell carcinomas

  1. Dash, S.
  2. Hanson, S.
  3. King, B.
  4. Nyswaner, K.
  5. Foss, K.
  6. Tesi, N.
  7. Harvey, M.J.B.
  8. Navarro-Marchal, S.A.
  9. Woods, A.
  10. Poradosu, E.
  11. Unciti-Broceta, A.
  12. Carragher, N.O.
  13. Brognard, J.
Aldizkaria:
Journal of Biological Chemistry

ISSN: 1083-351X,  0021-9258

Argitalpen urtea: 2024

Alea: 300

Zenbakia: 9

Mota: Artikulua

DOI: 10.1016/J.JBC.2024.107615 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus